FOXM1 and esophageal squamous cell carcinoma: In conclusion, both in vitro and in vivo findings suggested that FoxM1 knockdown sensitized ESCC cells to radiotherapy by impairing DNA damage response, arresting cell in G2/M phase, and enhancing cell apoptosis.